Twilight MasqueradeTwilight Masquerade🃏All Dipplin cards
Ask about Dipplin
Dipplin #18 Pokémon card from Twilight Masquerade

Dipplin 18/167

Twilight Masquerade

Find this card on eBay

Affiliate link · we may earn commission

Dipplin #18 from Twilight Masquerade currently trades at $0.40 raw, with PSA 10 copies reaching $48.80 — a 122.0x grade premium.
Current Prices (USD)
Ungraded
$0.40
PSA 7
$10.70
PSA 8
$10.70
PSA 9
$10.70
PSA 10
$48.80
ACE 10
BGS 10 Black
$315.00
CGC 10 Pristine
$52.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Dipplin 18/167 from Twilight Masquerade has a current raw market value of $0.40.

Current raw value
$0.40
PSA 9 value
$10.70
PSA 10 value
$48.80
View all cards from Twilight Masquerade
Collector Intel
122.0x
Raw → PSA 10
High-risk grade
26.8x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 122x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$49
PSA 10 Value
+$23
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1126.8x raw
PSA 10$49122.0x raw

Frequently asked questions

How much is Dipplin #18 from Twilight Masquerade worth?+
Dipplin #18 from Twilight Masquerade is currently worth Raw: $0.40, PSA 9: $10.70, PSA 10: $48.80 based on recent sold listings. Prices update daily from real eBay sales.
Is Dipplin #18 worth grading?+
The PSA 10 price of $48.80 is 122.0× the raw price of $0.40. After a ~$25 grading fee, a PSA 10 result would net approximately $48.40 — assuming the card grades a 10.
Where do PokePrices Dipplin #18 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.